Chapter 1 Cell Physiology
Clinical note: There are more than 45 lysosomal storage diseases, caused by impairment of lysosomal function, usually secondary to an inherited deficiency in a hydrolytic enzyme (Table 1-3). The resulting lipid accumulation within lysosomes eventually hinders the activity of cells in many organs, including the liver, heart, and brain. As with I-cell disease, clinical symptoms are severe, and average life expectancy across the entire group of diseases is approximately 15 years, reflecting the importance of normal lysosomal function.
Pharmacology note: Cardiac glycosides such as ouabain and digitalis inhibit the Na+,K+-ATPase (sodium) pump in the myocardium (see Fig. 1-6). This increases the amount of sodium inside the cell, triggering the Ca2+-Na+ countertransporter. More calcium is brought into the cell, which increases the contraction of atrial and ventricular myocardium and increases cardiac output.